Overview

Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is for compassionate use of nitazoxanide in the treatment of diarrheal disease due to Clostridium difficile infection when the patient has failed previous treatment with metronidazole or vancomycin.
Phase:
Phase 3
Details
Lead Sponsor:
Daniel M. Musher MD
VA Medical Center, Houston
Collaborator:
Baylor College of Medicine
Treatments:
Nitazoxanide